Latest news

Board welcomes Andrew Mills as CEO

The Board of Arthritis Australia is pleased to announce we have appointed Andrew Mills as our new CEO.

CEO Announcement

After 12 years at the helm of Arthritis Australia as Chief Executive Officer, Ainslie Cahill will be moving on to new adventures and challenges, leaving behind a valued organisation as well as a legacy of professionalism and integrity.

AGM update

We congratulate Kristine Riethmiller who was elected as Arthritis Australia’s new Chair and Roger Mattar as Deputy Chair following our recent AGM. We would like to express our sincere thanks to Roger for his leadership as Chair since 2014 and to David Motteram OAM who stepped down as Deputy Chair, a position he has held…

Minister commits to a National Strategic Action Plan for Arthritis

In a major milestone for our advocacy efforts, the Minister for Health, the Hon Greg Hunt, has committed to work with Arthritis Australia to develop a National Strategic Action Plan for Arthritis. The Minister made the announcement at a Parliamentary Friends of Arthritis breakfast in October 2017. As a first step in developing the Action…

Nurses the key to caring for arthritis

Rheumatology nurses could be the answer to improving care for hundreds of thousands of Australians with inflammatory arthritis. Around 1.7 million Australians suffer with chronic, inflammatory forms of arthritis, yet there is a severe shortage of the specialist nurses who are trained to help care for these patients. The report Rheumatology nurses: Adding value to…

New Osteoarthritis of the Knee Clinical Care Standard Launched

People with osteoarthritis of the knee should start to receive more consistent and appropriate care following the release of a new clinical care standard for the condition. A consumer fact sheet about the new standards outlines what they mean for people living with knee osteoarthritis. The standard was developed by the Australian Commission on Safety…

The hidden struggle: the impact of arthritis on emotional wellbeing

To mark this year’s Arthritis Awareness Week (28 May-3 June), Arthritis Australia has today announced its commitment to help improve the mental health of Australians living with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA). This coincides with the unveiling of new features on its online resource, EMPOWERED, which will further enhance its support…

Biosimilar etanercept now available – Important information for consumers

Are you on etanercept (Enbrel®) for rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis? If so, you should be aware that a new biosimilar brand of etanercept is now available on the Pharmaceutical Benefits Scheme (PBS). This version is marketed under the brand name Brenzys®. You should discuss brand choice with your rheumatologist. About Enbrel® and Brenzys®…

How bacteria contribute to spondyloarthritis

Bacteria in your gut may contribute to spondyloarthritis. Research funded by Arthritis Australia seeks to find out if altering these bacteria could eliminate or reduce the severity of this condition. This article first appeared in the limbic newsletter. Linda Rehaume’s research is supported by Arthritis Australia’s National Research Grants program. Linda Rehaume – The Limbic…

Arthritis – Count the Costs and Bank the Savings

A major new report shows the growing multi-billion dollar costs of arthritis to the economy, individuals and to the healthcare system and how relatively small investments could yield savings of more than $170 million a year. Media release: Key findings of the report include: There are 3.9 million Australians with arthritis and this will grow…